| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/23/2003 | US20030199564 Indane derivatives |
| 10/23/2003 | US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 10/23/2003 | US20030199562 Substituted benzoxazoles as estrogenic agents |
| 10/23/2003 | US20030199561 Boronic ester and acid compounds, synthesis and uses |
| 10/23/2003 | US20030199559 Process for making amlodipine maleate |
| 10/23/2003 | US20030199558 Can be used for lightening skin and for treating uneven skin complexions which result from hyperpigmentation-related medical conditions such as melasma, age spots, freckles, ochronosis, and lentigo |
| 10/23/2003 | US20030199557 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 10/23/2003 | US20030199556 beta3- adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof |
| 10/23/2003 | US20030199555 Indoline compounds and to pharmaceutical compositions containing them |
| 10/23/2003 | US20030199554 2,3-Disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| 10/23/2003 | US20030199553 Antidiabetic agents |
| 10/23/2003 | US20030199552 Amide derivatives as NMDA receptor antagonists |
| 10/23/2003 | US20030199551 Calcium blockers to treat proliferative vitreoretinopathy |
| 10/23/2003 | US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia |
| 10/23/2003 | US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders |
| 10/23/2003 | US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management |
| 10/23/2003 | US20030199547 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 10/23/2003 | US20030199546 6-(((2S)-2-(alkoxycabonyl)-4,4-difluoropyrrolidinyl)methyl)-1, 2, 3.4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylate, or acid derivatives, useful for treating migraine, and dural protein extravasation |
| 10/23/2003 | US20030199545 New esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions |
| 10/23/2003 | US20030199544 Substituted piperidines, useful for treating cancer |
| 10/23/2003 | US20030199541 topical bactericides and disinfectants for surgical instruments; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen; (SML pat indexing merged to app) |
| 10/23/2003 | US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles |
| 10/23/2003 | US20030199538 Imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines and other amines containing heterocyclic rings, a fatty acid and a hydrophobic, aprotic component miscible with fatty acid; useful for skin disorders |
| 10/23/2003 | US20030199537 Macrocyclic lactone useful in immunosuppressant therapy |
| 10/23/2003 | US20030199535 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent |
| 10/23/2003 | US20030199534 Kinase inhibitors |
| 10/23/2003 | US20030199532 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists |
| 10/23/2003 | US20030199530 New compounds derived from quinazoline |
| 10/23/2003 | US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 10/23/2003 | US20030199528 Such as cis-8-(2-aminocyclohexylamino)-7-benzyl-3-methyl-1-(2-oxo-2-phenylehtyl)-3,7-dihydropurine-2,6-dione for inhibition of dipeptidyl peptidase-IV (DPP-IV); for treatment of diabetes/obesity |
| 10/23/2003 | US20030199527 Such as 3-((4-methyl-benzyl)-(3,6-dimethyl-1-(2,4,6-trimethylphenyl)-1H-pyrazolo -(3,4-d)pyrimidin-4-yl)-amino)prop an-1-ol for treating/preventing Syndrome X; kits |
| 10/23/2003 | US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 10/23/2003 | US20030199525 Kinase inhibitors |
| 10/23/2003 | US20030199523 Such as N-2-(5-trifluoromethyl-1,3,4-thiadiazolyl)-3-(2,4-dichlorophenoxy)propionyl amide for treatment of stroke and pain |
| 10/23/2003 | US20030199521 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 10/23/2003 | US20030199519 Prodrugs of CC-1065 analogs |
| 10/23/2003 | US20030199518 Administering adrenergic receptor antagonist such as prazosin to treat hepatits/liver disorders |
| 10/23/2003 | US20030199517 Comprises 2-(2-propoxyphenyl)-8-azapurin-6-one (zaprinast); for treatment of benign prostatic hyperplasia and urination disorders |
| 10/23/2003 | US20030199516 Methods of treating infection by drug resistant bacteria |
| 10/23/2003 | US20030199515 Method for the preparation of crystalline tetrahydrobenzothiepines |
| 10/23/2003 | US20030199514 Methods for improving efficacy of treatment with growth hormone secretagogues |
| 10/23/2003 | US20030199513 Cinnoline derivatives and use as medicine |
| 10/23/2003 | US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 10/23/2003 | US20030199509 For treatment of glaucoma and/or ocular hypertension |
| 10/23/2003 | US20030199507 Combination of brimonidine and timolol for topical ophthalmic use |
| 10/23/2003 | US20030199505 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations |
| 10/23/2003 | US20030199504 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations |
| 10/23/2003 | US20030199502 Indoloquinazolinones |
| 10/23/2003 | US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 10/23/2003 | US20030199500 Tetrahydrofuran derivatives and their use as nk-1 antagonists |
| 10/23/2003 | US20030199499 Novel guanidinobenzamides |
| 10/23/2003 | US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 10/23/2003 | US20030199497 Novel calcium receptor active molecules and method for preparing same |
| 10/23/2003 | US20030199496 Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use |
| 10/23/2003 | US20030199494 1,2,3,5-tetrahydrobenzo'c!azepin-4-one derivatives having muscarinic antagonist activity |
| 10/23/2003 | US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma |
| 10/23/2003 | US20030199492 Combination therapy |
| 10/23/2003 | US20030199491 Quinoline derivatives having vegf inhibiting activity |
| 10/23/2003 | US20030199489 Small molecule inhibitors targeted at BCL-2 |
| 10/23/2003 | US20030199488 A therapeutic mixture comprising corticosteroid and a gelatinous paste; treating psoriasis, skin disorders |
| 10/23/2003 | US20030199487 Ester and ether derivatives of 4-hydroxytestosterone and a method for the regulation of athletic function in humans |
| 10/23/2003 | US20030199486 A dietary supplement |
| 10/23/2003 | US20030199485 Novel anti-inflammatory androstane derivative |
| 10/23/2003 | US20030199484 Method for the treatment of urinary incontinence |
| 10/23/2003 | US20030199483 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of pathogenic conditions |
| 10/23/2003 | US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2 |
| 10/23/2003 | US20030199480 Modified release preparation |
| 10/23/2003 | US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug |
| 10/23/2003 | US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 10/23/2003 | US20030199476 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 10/23/2003 | US20030199475 Selectively inhibiting selectin mediated binding in a subject by administering an amount of heparin that does not produce substantial anticoagulant activity or undesirable bleeding |
| 10/23/2003 | US20030199474 Administering compounds such as (3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione for inhibiting the invasion and/or metastasis of a carcinoma in a mammal |
| 10/23/2003 | US20030199473 For therapy of retrovirus infection |
| 10/23/2003 | US20030199466 For modulating an immune response |
| 10/23/2003 | US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 10/23/2003 | US20030199463 For therapy of cardiovascular disease, fibrotic disease |
| 10/23/2003 | US20030199461 3-beta-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof |
| 10/23/2003 | US20030199459 Macrolides with antibacterial activity |
| 10/23/2003 | US20030199457 Prevention and treatment of thromboembolic disorders associated with arterial & venous thrombosis |
| 10/23/2003 | US20030199456 Sodium channel blockers |
| 10/23/2003 | US20030199446 Stabilizers of DNA to prevent mutations caused by ultriviolet radiation and resulting in skin tumour cells; topical; anticarcinogenic and -tumor agents; sunscreen agents; stabilizers of gene p53 and protein p53 |
| 10/23/2003 | US20030199439 Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics |
| 10/23/2003 | US20030199437 Identification, isolation and recombinant production of novel DNA; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules; fused heterologous polypeptide sequences, binding antibodies; anticarcinogenic |
| 10/23/2003 | US20030199436 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199435 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2003 | US20030199430 Zinc compounds such as zinc gluconate, zinc acetate, or zinc citrate; and glycine, leucine, isoleucine, lysine, valine or isovaline |
| 10/23/2003 | US20030199427 Increased or improved bioavailability of the active agent |
| 10/23/2003 | US20030199425 Administering a drug that inhibits proliferation and cell migration, and a biocompatible protein; reduced toxicity. |
| 10/23/2003 | US20030199424 of a neuropathic condition, by administering anangiotensin II receptor I (AT1 receptor) antagonists |
| 10/23/2003 | US20030199103 Novel amino acid sequences for human epidermal growth factor-like polypeptides |
| 10/23/2003 | US20030199075 Compactin is provided and contacted with Actinomadura bacteria containing hydroxylase under hydroxylation condition to convert compactin to pravastatin, useful for lowering cholesterol levels in mammals |
| 10/23/2003 | US20030199070 Crystallization of ribosome recycling factor (RRF) and method of developing inhibitor of RRF |
| 10/23/2003 | US20030199067 Growth arrest homeobox gene |
| 10/23/2003 | US20030199046 Processes and intermediates useful in preparing beta3-adrenergic receptor agonists |
| 10/23/2003 | US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA |
| 10/23/2003 | US20030198992 Treatment or prophylaxis of diseases caused by pilus-forming bacteria |
| 10/23/2003 | US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX) |
| 10/23/2003 | US20030198982 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 10/23/2003 | US20030198949 Viral polypeptides that regulate or modulate apoptosis |
| 10/23/2003 | US20030198728 Mixture of linoleic acid and other fatty acids |